Literature DB >> 29396052

TGF-beta signaling in cancer: post-transcriptional regulation of EMT via hnRNP E1.

Breege V Howley1, Philip H Howe2.   

Abstract

The TGFβ signaling pathway is a critical regulator of cancer progression in part through induction of the epithelial to mesenchymal transition (EMT). This process is aberrantly activated in cancer cells, facilitating invasion of the basement membrane, survival in the circulatory system, and dissemination to distant organs. The mechanisms through which epithelial cells transition to a mesenchymal state involve coordinated transcriptional and post-transcriptional control of gene expression. One such mechanism of control is through the RNA binding protein hnRNP E1, which regulates splicing and translation of a cohort of EMT and stemness-associated transcripts. A growing body of evidence indicates a major role for hnRNP E1 in the control of epithelial cell plasticity, especially in the context of carcinoma progression. Here, we review the multiple mechanisms through which hnRNP E1 functions to control EMT and metastatic progression.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EMT; Metastasis; TGFβ signaling; hnRNP E1

Mesh:

Substances:

Year:  2018        PMID: 29396052      PMCID: PMC6063801          DOI: 10.1016/j.cyto.2017.12.032

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  122 in total

Review 1.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

Review 2.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Suppression of 15-lipoxygenase synthesis by hnRNP E1 is dependent on repetitive nature of LOX mRNA 3'-UTR control element DICE.

Authors:  Iris Reimann; Antje Huth; Holger Thiele; Bernd-Joachim Thiele
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

4.  Identification of two novel mammalian genes establishes a subfamily of KH-domain RNA-binding proteins.

Authors:  A V Makeyev; S A Liebhaber
Journal:  Genomics       Date:  2000-08-01       Impact factor: 5.736

Review 5.  CD44: from adhesion molecules to signalling regulators.

Authors:  Helmut Ponta; Larry Sherman; Peter A Herrlich
Journal:  Nat Rev Mol Cell Biol       Date:  2003-01       Impact factor: 94.444

6.  A novel set of nuclear localization signals determine distributions of the alphaCP RNA-binding proteins.

Authors:  Alexander N Chkheidze; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

7.  Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT).

Authors:  Céline Prunier; Philip H Howe
Journal:  J Biol Chem       Date:  2005-02-25       Impact factor: 5.157

Review 8.  TGF-beta signaling in tumor suppression and cancer progression.

Authors:  R Derynck; R J Akhurst; A Balmain
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

9.  Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions.

Authors:  Aśok Antony; Ying-Sheng Tang; Rehana A Khan; Mangatt P Biju; Xiangli Xiao; Qing-Jun Li; Xin-Lai Sun; Hiremagalur N Jayaram; Sally P Stabler
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

10.  Regulation of the Wnt signaling pathway by disabled-2 (Dab2).

Authors:  B A Hocevar; F Mou; J L Rennolds; S M Morris; J A Cooper; P H Howe
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  8 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

2.  B7-1 drives TGF-β stimulated pancreatic carcinoma cell migration and expression of EMT target genes.

Authors:  Jeong-Han Kang; Mi-Yeon Jung; Edward B Leof
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

3.  RNA-Binding Protein La Mediates TGFβ-Induced Epithelial to Mesenchymal Transition and Cancer Stem Cell Properties.

Authors:  Tilman Heise; Gunhild Sommer
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

Review 4.  RNA-binding proteins in tumor progression.

Authors:  Hai Qin; Haiwei Ni; Yichen Liu; Yaqin Yuan; Tao Xi; Xiaoman Li; Lufeng Zheng
Journal:  J Hematol Oncol       Date:  2020-07-11       Impact factor: 17.388

5.  STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer.

Authors:  Yuan-Yu Wu; Jun-Nan Jiang; Xue-Dong Fang; Fu-Jian Ji
Journal:  Front Physiol       Date:  2018-08-21       Impact factor: 4.566

6.  RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity.

Authors:  Ephraim A Ansa-Addo; Huai-Cheng Huang; Brian Riesenberg; Supinya Iamsawat; Davis Borucki; Michelle H Nelson; Jin Hyun Nam; Dongjun Chung; Chrystal M Paulos; Bei Liu; Xue-Zhong Yu; Caroline Philpott; Philip H Howe; Zihai Li
Journal:  Sci Adv       Date:  2020-05-29       Impact factor: 14.136

7.  The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression.

Authors:  Breege V Howley; Bidyut Mohanty; Annamarie Dalton; Simon Grelet; Joseph Karam; Toros Dincman; Philip H Howe
Journal:  Oncogene       Date:  2022-01-31       Impact factor: 8.756

8.  Heterogeneous nuclear ribonucleoprotein E1 binds polycytosine DNA and monitors genome integrity.

Authors:  Bidyut K Mohanty; Joseph Aq Karam; Breege V Howley; Annamarie C Dalton; Simon Grelet; Toros Dincman; William S Streitfeld; Je-Hyun Yoon; Lata Balakrishnan; Walter J Chazin; David T Long; Philip H Howe
Journal:  Life Sci Alliance       Date:  2021-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.